J. Goldman & Co LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$307,125
-95.2%
67,500
-93.6%
0.01%
-95.8%
Q1 2023$6,456,217
+673.2%
1,056,664
+5770.4%
0.26%
+521.4%
Q4 2020$835,000
-70.7%
18,000
-81.1%
0.04%
-87.8%
Q1 2020$2,850,00095,2050.34%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders